Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BFLY
BFLY logo

BFLY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.540
Open
5.360
VWAP
5.42
Vol
3.49M
Mkt Cap
1.39B
Low
5.210
Amount
18.89M
EV/EBITDA(TTM)
--
Total Shares
254.63M
EV
1.24B
EV/OCF(TTM)
--
P/S(TTM)
13.80
Butterfly Network, Inc. is a healthcare company focused on medical imaging with its Ultrasound-on-Chip semiconductor technology and ultrasound software solutions. The Company's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.
Show More

Events Timeline

(ET)
2026-03-30
08:10:00
Butterfly Network Receives FDA Clearance for Automated Gestational Age Tool
select
2026-02-26 (ET)
2026-02-26
16:30:00
Nasdaq Lags Despite Nvidia's Earnings Beat and Strong Guidance
select
2026-02-26
12:20:00
Nasdaq Index Falls 1.63% as Market Confidence Wanes
select
2026-02-26
11:20:00
Butterfly Reports Q4 Revenue of $31.5M, Up 41%
select
2026-02-26
07:40:00
Butterfly Reports Q4 Revenue of $31.5M, Up 41% Year Over Year
select
2026-02-26
07:40:00
Sees FY26 Adjusted EBITDA of $21M-$25M
select
2026-01-13 (ET)
2026-01-13
15:20:00
Butterfly Network Expects Q4 2025 Revenue Growth of At Least 17%
select

News

Yahoo Finance
8.5
04-19Yahoo Finance
PinnedButterfly Network Secures FDA Approval, Stock Surges 90%
  • FDA Approval for New Tool: On March 30, Butterfly Network announced it secured FDA approval for its AI-powered handheld ultrasound tool that estimates gestation age in under two minutes, significantly enhancing clinical decision-making efficiency, especially in emergencies or rural settings.
  • Massive Market Potential: According to Fortune Business Insights, the global handheld ultrasound market is projected to grow from $397.29 million in 2025 to $1.13 billion by 2034, with Butterfly Network aiming to capture a share of this rapidly expanding market.
  • Strong Financial Performance: In Q4 2025, Butterfly reported revenue of $31.5 million, a 41% year-over-year increase that exceeded the consensus estimate of $25.6 million, indicating robust growth potential in the medical imaging device sector.
  • Healthy Cash Flow: Butterfly ended 2025 with $150.5 million in cash reserves, enhancing its financial flexibility in market competition and supporting future product development and market expansion.
Newsfilter
8.5
03-30Newsfilter
Butterfly Network Receives FDA Clearance for AI Gestational Age Tool
  • FDA Approval: Butterfly Network's fully automated Gestational Age Tool has received FDA clearance, marking it as the first blind-sweep ultrasound AI tool aimed at enhancing the timeliness and accuracy of maternal care globally, which is expected to significantly reduce maternal and fetal mortality rates.
  • Technological Innovation: The tool employs deep learning models to deliver reliable gestational age estimates in under two minutes, minimizing user variability and improving decision-making efficiency in emergency settings, particularly in resource-limited areas.
  • Global Impact: Already deployed in Malawi and Uganda, the tool aims to improve access to prenatal ultrasound in countries with high maternal and neonatal mortality rates, and FDA clearance will expedite its expansion across Sub-Saharan Africa, supporting global health initiatives.
  • Market Potential: With the U.S. federal rural health transformation initiatives underway, the launch of this tool comes at a crucial time, expected to provide easier access to healthcare for pregnant women in remote areas, thereby enhancing overall healthcare accessibility.
NASDAQ.COM
7.5
03-27NASDAQ.COM
Butterfly Network and GE Healthcare's AI Technology Competition
  • Butterfly Financial Improvement: Butterfly Network achieved positive cash flow in Q1 2026 with revenue of $31.5 million, a 44% year-over-year increase, despite a per-share loss improving from $0.08 to $0.06, indicating initial success in its transition to a software platform that may attract more investor interest in its growth potential.
  • GE Healthcare AI Strategy: GE Healthcare's Edison Digital Health Platform features over 40 AI applications, with the latest FDA-approved Photonova Spectra CT scanner enhancing imaging quality for cardiology patients by counting and measuring individual X-ray photons, showcasing its technological advancements and market competitiveness in medical imaging.
  • Market Competition Dynamics: Although GE Healthcare's market cap is over 30 times that of Butterfly Network, its stock has declined more than 11% in the past year, reflecting market caution regarding its shift to AI software, while Butterfly Network's innovative CMUT technology and lower device costs demonstrate higher growth potential.
  • Investment Risk Assessment: As a younger company, Butterfly Network faces risks due to lack of profitability and economic downturn threats, while GE Healthcare, with stable cash flow and a diverse product line, presents a stronger risk mitigation profile, potentially making it a safer investment choice.
Fool
7.5
03-27Fool
Medical Diagnostic Stocks Benefit from AI Surge
  • Butterfly Network's Recovery: Butterfly Network has successfully transitioned from hardware sales to a software platform and AI company by utilizing capacitive micromachined ultrasonic transducer technology, achieving its first positive cash flow in Q1 2026, with stock prices rising over 9%.
  • Significant Revenue Growth: The company reported Q4 revenue of $31.5 million, a 44% year-over-year increase, with software and services accounting for 43% of total revenue, indicating high-margin potential in its software business, although it still posted a loss per share that needs monitoring for profitability.
  • GE HealthCare's Transition Challenges: Despite being over 30 times larger than Butterfly Network, GE HealthCare's shares have fallen over 11% in the past year as it shifts focus from medical device hardware to AI software aimed at improving image quality and hospital workflows.
  • AI Application Approval: GE HealthCare's latest AI-powered application, Photonova Spectra, has received FDA clearance to enhance CT scans for cardiology patients, with projected organic revenue growth of 3% to 4% in 2026, showcasing its ongoing investment potential in AI.
Benzinga
2.0
03-08Benzinga
Benzinga Stock Whisper Index Analysis for the Week Ending March 6
  • Investor Focus: Benzinga's Stock Whisper Index utilizes proprietary data and pattern recognition each week to highlight five undervalued and under-followed stocks, aiding investors in uncovering potential opportunities.
  • Information Overload Challenge: Retail traders face the challenge of sifting through an abundance of methods to identify stocks worth attention, underscoring the complexity of market information.
  • Market Dynamics Tracking: Benzinga Pro offers the latest market dynamics and headlines, ensuring investors can stay updated on significant events and trends that impact the market, enhancing decision-making efficiency.
  • Future Report Preview: Benzinga encourages investors to look forward to next week's report, continuously tracking market movements to seize potential investment opportunities.
PRnewswire
7.5
03-03PRnewswire
VentriPoint Partners with LG Consulting for VMS+ Deployment
  • Market Potential: The AI medical imaging market is projected to reach nearly $20 billion by 2033, growing at a CAGR of 34.7%, indicating a rapid increase in demand for AI technologies in healthcare, which positions VentriPoint favorably for market share expansion.
  • Echocardiography Growth: The echocardiography market is expected to grow to $2.64 billion by 2030, driven by hospitals' dual demand for economic value and clinical accuracy, making VentriPoint's VMS+™ system well-suited to meet this market need.
  • Strategic Partnership: The commercial agreement between VentriPoint and LG Consulting Solutions will support the deployment of the VMS+™ system across Northern California, with LG providing economic analysis and clinical implementation support to help hospitals evaluate the economic and clinical value of VMS+™, thereby accelerating technology adoption.
  • Demonstration Platform Development: LG Consulting Solutions will purchase a VMS+™ system as a demonstration platform to support hospital engagement, clinician training, and economic value assessments, which not only enhances cardiac care pathways but also presents potential revenue-sharing opportunities for VentriPoint.
Wall Street analysts forecast BFLY stock price to rise
4 Analyst Rating
Wall Street analysts forecast BFLY stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
4.00
Averages
4.25
High
4.50
Current: 0.000
sliders
Low
4.00
Averages
4.25
High
4.50
TD Cowen
Buy
upgrade
$6
AI Analysis
2026-02-27
Reason
TD Cowen
Price Target
$6
AI Analysis
2026-02-27
upgrade
Buy
Reason
TD Cowen raised the firm's price target on Butterfly Network to $6 from $4.50 and keeps a Buy rating on the shares. The firm said they reported strng Q4 results and Butterfly Embedded should become a bigger part of the story and the stock price as the company supplements its core POCUS business with this new revenue stream, making it more tech than med tech.
Craig-Hallum
Craig-Hallum
maintain
2026-01-21
Reason
Craig-Hallum
Craig-Hallum
Price Target
2026-01-21
maintain
Reason
Craig-Hallum raised the firm's price target on Butterfly Network to $5.25 from $3.25 and keeps a Buy rating on the shares following the company's recent announcements, including at least 17% year-over-year Q4 revenue growth, implying $26.2M vs. Street's $25.7M, with the full year landing at $92.3M. While some Q4 revenue came from the Midjourney partnership, the firm notes core business was the majority of growth.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BFLY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Butterfly Network Inc (BFLY.N) is 0.00, compared to its 5-year average forward P/E of -7.20. For a more detailed relative valuation and DCF analysis to assess Butterfly Network Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-7.20
Current PE
0.00
Overvalued PE
-1.11
Undervalued PE
-13.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-8.11
Current EV/EBITDA
-28.54
Overvalued EV/EBITDA
-1.25
Undervalued EV/EBITDA
-14.97

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
9.26
Current PS
9.60
Overvalued PS
17.25
Undervalued PS
1.26

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Which stocks will be top movers tomorrow?
Intellectia · 37 candidates
Option Iv Rank: >= 30One Day Predict Return: 2.0% - 100.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
QUIK logo
QUIK
Quicklogic Corp
211.58M
MTCH logo
MTCH
Match Group Inc
8.26B
SANM logo
SANM
Sanmina Corp
9.51B
OTLK logo
OTLK
Outlook Therapeutics Inc
32.35M
KTOS logo
KTOS
Kratos Defense and Security Solutions Inc
13.30B
AVAV logo
AVAV
AeroVironment Inc
9.56B
what penny stocks are people buying
Intellectia · 42 candidates
Market Cap: 50.00M - 2.00BPrice: $0.10 - $5.00Price Change Pct: >= $3.00Relative Vol: >= 1.50Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
EONR logo
EONR
EON Resources Inc
67.46M
BYND logo
BYND
Beyond Meat Inc
331.79M
OCGN logo
OCGN
Ocugen Inc
767.28M
UPXI logo
UPXI
Upexi Inc
64.91M
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
1.74B
FUBO logo
FUBO
FuboTV Inc
1.50B
Best Penny Stocks to buy for tomorrow
Intellectia · 45 candidates
Market Cap: 50.00M - 2.00BRegion: USPrice: $0.50 - $5.00Volume: >= 1,000,000List Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 55One Day Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
ABAT logo
ABAT
American Battery Technology Co
450.45M
GORO logo
GORO
Gold Resource Corp
224.98M
ALT logo
ALT
Altimmune Inc
468.25M
HTZ logo
HTZ
Hertz Global Holdings Inc
1.22B
CCO logo
CCO
Clear Channel Outdoor Holdings Inc
1.18B
NB logo
NB
NioCorp Developments Ltd
683.66M
news about stocks that are below 10 dollar
Intellectia · 100 candidates
Region: USPrice: $1.00 - $10.00Relative Vol: >= 2List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000News Driver: Positive, Negative
Ticker
Name
Market Cap$
top bottom
XWEL logo
XWEL
XWELL Inc
6.98M
LRMR logo
LRMR
Larimar Therapeutics Inc
494.39M
VSME logo
VSME
VS Media Holdings Ltd
5.06M
EVH logo
EVH
Evolent Health Inc
350.52M
NVTS logo
NVTS
Navitas Semiconductor Corp
2.27B
SBET logo
SBET
Sharplink Inc
1.46B
What penny stocks to buy in 2026
Intellectia · 34 candidates
Market Cap: 200.00M - 2.00BPrice: $0.25 - $5.00Weekly Average Turnover: >= 2,000,000Moving Average Relationship: PriceAboveMA20Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
RZLV logo
RZLV
Rezolve AI PLC
1.43B
BORR logo
BORR
Borr Drilling Ltd
1.34B
BFLY logo
BFLY
Butterfly Network Inc
1.12B
GROY logo
GROY
Gold Royalty Corp
1.10B
EVGO logo
EVGO
EVgo Inc
951.67M
ECX logo
ECX
Ecarx Holdings Inc.
734.56M
to increase in price
Intellectia · 25 candidates
Market Cap: >= 500.00MPrice: <= $5.00Analyst Consensus: Moderate Buy, Strong BuyMoving Average Relationship: PriceAboveMA20Annual Eps Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
AUR logo
AUR
Aurora Innovation Inc
9.02B
BTE logo
BTE
Baytex Energy Corp
2.64B
NWL logo
NWL
Newell Brands Inc
1.79B
CLOV logo
CLOV
Clover Health Investments Corp
1.35B
BORR logo
BORR
Borr Drilling Ltd
1.34B
SANA logo
SANA
Sana Biotechnology Inc
1.27B
any penny stock?
Intellectia · 72 candidates
Market Cap: 50.00M - 2.00BPrice: <= $5.00Beta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
BITF logo
BITF
Bitfarms Ltd
1.61B
BORR logo
BORR
Borr Drilling Ltd
1.34B
TUYA logo
TUYA
Tuya Inc
1.31B
TBLA logo
TBLA
Taboola.com Ltd
1.18B
BFLY logo
BFLY
Butterfly Network Inc
1.12B
ASST logo
ASST
Strive Inc
1.11B
penny stocks on the move today
Intellectia · 52 candidates
Price: <= $5.00Price Change Pct: >= $1.00Relative Vol: >= 1Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
RIG logo
RIG
Transocean Ltd
5.10B
DNN logo
DNN
Denison Mines Corp
3.36B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
TV logo
TV
Grupo Televisa SAB
1.74B
CLOV logo
CLOV
Clover Health Investments Corp
1.35B
BAK logo
BAK
Braskem SA
1.31B
I want to buy penny stock
Intellectia · 182 candidates
Market Cap: <= 2.00BPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
MQ logo
MQ
Marqeta Inc
1.94B
CLVT logo
CLVT
Clarivate PLC
1.86B
NWL logo
NWL
Newell Brands Inc
1.79B
TV logo
TV
Grupo Televisa SAB
1.74B
BITF logo
BITF
Bitfarms Ltd
1.61B
PGEN logo
PGEN
Precigen Inc
1.58B

Whales Holding BFLY

G
Glenview Capital Management, LLC
Holding
BFLY
+1.88%
3M Return
F
Fosun International Holdings Ltd.
Holding
BFLY
-0.29%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Butterfly Network Inc (BFLY) stock price today?

The current price of BFLY is 5.495 USD — it has increased 0.83

What is Butterfly Network Inc (BFLY)'s business?

Butterfly Network, Inc. is a healthcare company focused on medical imaging with its Ultrasound-on-Chip semiconductor technology and ultrasound software solutions. The Company's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.

What is the price predicton of BFLY Stock?

Wall Street analysts forecast BFLY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BFLY is4.25 USD with a low forecast of 4.00 USD and a high forecast of 4.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Butterfly Network Inc (BFLY)'s revenue for the last quarter?

Butterfly Network Inc revenue for the last quarter amounts to 31.51M USD, increased 41.00

What is Butterfly Network Inc (BFLY)'s earnings per share (EPS) for the last quarter?

Butterfly Network Inc. EPS for the last quarter amounts to -0.06 USD, decreased -25.00

How many employees does Butterfly Network Inc (BFLY). have?

Butterfly Network Inc (BFLY) has 220 emplpoyees as of April 20 2026.

What is Butterfly Network Inc (BFLY) market cap?

Today BFLY has the market capitalization of 1.39B USD.